FN1 and gastric cancer: Gastric cancer patients with high expression levels of FN1 (HR = 1.54, P < 0.05), MAC25 (HR = 1.48, P < 0.05), THBS2 (HR = 1.55, P < 0.05), VCAN (HR = 1.32, P = 0.0031), SPARC (HR = 1.42, P < 0.05), MSLN (HR = 1.28, P = 0.0066), and FGA (HR = 1.37, P < 0.05) had shorter survival time (Figure 6).